Apollo Hospitals Enterprise Limited (APOLLOHOSP) — Board Meeting | 12 August 2025

· NSE 🟡 Notable ✨ Positive
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Apollo Hospitals reported Q1 FY26 consolidated revenue of ₹5,842 crores with 15% YoY growth and net profit of ₹433 crores, up 42% YoY. The board approved acquisition of remaining 50% stake in Apollo Gleneagles PET-CT for ₹85 million, making it wholly-owned. Additionally, the company granted 327,494 stock options at ₹5,258 per share and approved a demerger scheme separating pharmacy and digital health businesses into Apollo HealthTech for listing. EBITDA grew 26% YoY to ₹852 crores.

📄 View Original Announcement (PDF)

About Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,16,213.95 Cr P/E: 64.5 ROE: 21.9% ROCE: 20.5%

View full APOLLOHOSP stock details →

📡 Get AI alerts when APOLLOHOSP files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track APOLLOHOSP — Free

📊 More APOLLOHOSP filings

See all APOLLOHOSP filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when APOLLOHOSP files new disclosures

Track APOLLOHOSP filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track APOLLOHOSP — Free

Free account · 2 AI queries/day